These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23600329)

  • 1. Restoration of IGFBP-rP1 increases radiosensitivity and chemosensitivity in hormone-refractory human prostate cancer.
    Seki M; Teishima J; Mochizuki H; Mutaguchi K; Yasumoto H; Oka K; Nagamatsu H; Shoji K; Matsubara A
    Hiroshima J Med Sci; 2013 Mar; 62(1):13-9. PubMed ID: 23600329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis in human prostate cancer.
    Mutaguchi K; Yasumoto H; Mita K; Matsubara A; Shiina H; Igawa M; Dahiya R; Usui T
    Cancer Res; 2003 Nov; 63(22):7717-23. PubMed ID: 14633696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer.
    Sprenger CC; Damon SE; Hwa V; Rosenfeld RG; Plymate SR
    Cancer Res; 1999 May; 59(10):2370-5. PubMed ID: 10344746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.
    Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR
    Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
    Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
    Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of fibroblast growth factor receptor 2IIIb enhances the chemosensitivity of human prostate cancer cells.
    Shoji K; Teishima J; Hayashi T; Ohara S; Mckeehan WL; Matsubara A
    Oncol Rep; 2014 Jul; 32(1):65-70. PubMed ID: 24839986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ProstaCaid inhibits tumor growth in a xenograft model of human prostate cancer.
    Jiang J; Loganathan J; Eliaz I; Terry C; Sandusky GE; Sliva D
    Int J Oncol; 2012 May; 40(5):1339-44. PubMed ID: 22293856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative chemosensitivity of circulating human prostate cancer cells and primary cancer cells.
    Menen R; Zhao M; Zhang L; Hassanein MK; Bobek V; Kolostova K; Bouvet M; Hoffman RM
    Anticancer Res; 2012 Jul; 32(7):2881-4. PubMed ID: 22753751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis.
    Yasukochi A; Kawakubo T; Nakamura S; Yamamoto K
    Biol Chem; 2010 Aug; 391(8):947-58. PubMed ID: 20482316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased manganese superoxide dismutase (SOD-2) is part of the mechanism for prostate tumor suppression by Mac25/insulin-like growth factor binding-protein-related protein-1.
    Plymate SR; Haugk KH; Sprenger CC; Nelson PS; Tennant MK; Zhang Y; Oberley LW; Zhong W; Drivdahl R; Oberley TD
    Oncogene; 2003 Feb; 22(7):1024-34. PubMed ID: 12592389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction.
    Xiao D; Lew KL; Kim YA; Zeng Y; Hahm ER; Dhir R; Singh SV
    Clin Cancer Res; 2006 Nov; 12(22):6836-43. PubMed ID: 17121905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
    Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
    Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer.
    Koike H; Ito K; Takezawa Y; Oyama T; Yamanaka H; Suzuki K
    Br J Cancer; 2005 Apr; 92(8):1538-44. PubMed ID: 15846301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium selenite radiosensitizes hormone-refractory prostate cancer xenograft tumors but not intestinal crypt cells in vivo.
    Tian J; Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):230-6. PubMed ID: 20615620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
    Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The suppression of aurora-A/STK15/BTAK expression enhances chemosensitivity to docetaxel in human esophageal squamous cell carcinoma.
    Tanaka E; Hashimoto Y; Ito T; Kondo K; Higashiyama M; Tsunoda S; Ortiz C; Sakai Y; Inazawa J; Shimada Y
    Clin Cancer Res; 2007 Feb; 13(4):1331-40. PubMed ID: 17317845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1/mac 25) is reduced in human prostate cancer and is inversely related to tumor volume and proliferation index in Lucap 23.12 xenografts.
    Tennant MK; Vessella RL; Sprenger CC; Sikes RA; Hwa V; Baker LD; Plymate SR
    Prostate; 2003 Jul; 56(2):115-22. PubMed ID: 12746836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo.
    Miyake H; Chi KN; Gleave ME
    Clin Cancer Res; 2000 May; 6(5):1655-63. PubMed ID: 10815883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin enhances the susceptibility of both androgen-dependent and -independent prostate carcinoma cells to docetaxel.
    Liu QJ; Xu XH; Shang DH; Tian Y; Lü WC; Zhang YH
    Chin Med J (Engl); 2010 Feb; 123(3):356-60. PubMed ID: 20193259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway.
    Zhang AL; Russell PJ; Knittel T; Milross C
    Prostate; 2007 Nov; 67(15):1630-40. PubMed ID: 17823933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.